Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Amortizatization of Intangibles: 2019-2025

Historic Amortizatization of Intangibles for Beam Therapeutics (BEAM) over the last 6 years, with Sep 2025 value amounting to $4.2 million.

  • Beam Therapeutics' Amortizatization of Intangibles fell 24.72% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year decrease of 31.94%. This contributed to the annual value of $22.8 million for FY2024, which is 23.46% down from last year.
  • According to the latest figures from Q3 2025, Beam Therapeutics' Amortizatization of Intangibles is $4.2 million, which was down 8.34% from $4.6 million recorded in Q2 2025.
  • Beam Therapeutics' 5-year Amortizatization of Intangibles high stood at $7.9 million for Q3 2023, and its period low was -$15,000 during Q1 2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $5.9 million (2024), whereas its average is $5.9 million.
  • Per our database at Business Quant, Beam Therapeutics' Amortizatization of Intangibles plummeted by 111.63% in 2021 and then soared by 12,768.00% in 2022.
  • Over the past 5 years, Beam Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $47,000 in 2021, then soared by 10,755.32% to $5.1 million in 2022, then soared by 44.14% to $7.4 million in 2023, then crashed by 36.91% to $4.6 million in 2024, then decreased by 24.72% to $4.2 million in 2025.
  • Its last three reported values are $4.2 million in Q3 2025, $4.6 million for Q2 2025, and $3.8 million during Q1 2025.